NYSE American Notifies General Moly About Low Share Price Continued Listing Deficiency

Author's Avatar
Sep 18, 2019
Article's Main Image

LAKEWOOD, CO / ACCESSWIRE / September 17, 2019 / General Moly, Inc. (the "Company" or "General Moly") (NYSE American and TSX: GMO), the only western-exchange listed, pure-play molybdenum mineral development company, announced that onSeptember 12, 2019, it received a deficiency letter ("Letter") from the NYSE American stock exchange indicating that pursuant to Section 1003(f)(v) of the NYSE American Company Guide, the Company's common stock has been selling for a low price per share for a substantial period of time. Accordingly, the Letter states that the Company must demonstrate an improved share price improvement or effect a reverse stock split of its common stock by no later than March 12, 2020, in order to maintain the listing of the Company's common stock on the NYSE American.